Unicycive Therapeutics, Inc.
UNCY · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $79 | $59 | $67 | $53 |
| - Cash | $43 | $22 | $20 | $26 |
| + Debt | $0 | $0 | $1 | $1 |
| Enterprise Value | $36 | $37 | $48 | $28 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$6 | -$6 | $1 | -$9 |
| % Margin | – | – | – | – |
| Net Income | -$6 | -$6 | $1 | -$22 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.33 | -0.52 | -0.502 | -2 |
| % Growth | 36.5% | -3.6% | 74.9% | – |
| Operating Cash Flow | -$6 | -$8 | -$9 | -$7 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$6 | -$8 | -$9 | -$7 |